Neil Kumar, the Chief Executive Officer of $BBIO, sold 7,200 shares of the company on 04-09-2026 for an estimated $530,239. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1% of their shares of this class of stock. Following this trade, they now own 628,486 shares of this class of $BBIO stock.
$BBIO Insider Trading Activity
$BBIO insiders have traded $BBIO stock on the open market 99 times in the past 6 months. Of those trades, 0 have been purchases and 99 have been sales.
Here’s a breakdown of recent trading of $BBIO stock by insiders over the last 6 months:
- NEIL KUMAR (Chief Executive Officer) has made 0 purchases and 74 sales selling 564,220 shares for an estimated $40,118,112.
- FRANK MCCORMICK has made 0 purchases and 6 sales selling 200,000 shares for an estimated $13,313,192.
- ANDREW LO has made 0 purchases and 4 sales selling 95,599 shares for an estimated $6,319,662.
- ANDREA ELLIS sold 64,921 shares for an estimated $4,211,301
- RONALD J DANIELS sold 61,031 shares for an estimated $3,888,999
- HANNAH VALANTINE has made 0 purchases and 2 sales selling 34,155 shares for an estimated $2,308,039.
- THOMAS TRIMARCHI (President and CFO) has made 0 purchases and 4 sales selling 30,534 shares for an estimated $2,141,551.
- RANDAL W. SCOTT has made 0 purchases and 5 sales selling 20,000 shares for an estimated $1,421,021.
- MARICEL APULI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 2,510 shares for an estimated $186,418.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BBIO Hedge Fund Activity
We have seen 236 institutional investors add shares of $BBIO stock to their portfolio, and 189 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,261,181 shares (+144.2%) to their portfolio in Q4 2025, for an estimated $172,957,734
- JANUS HENDERSON GROUP PLC added 2,259,378 shares (+25.8%) to their portfolio in Q4 2025, for an estimated $172,819,823
- MACQUARIE GROUP LTD removed 1,933,096 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $147,862,513
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,602,036 shares (-78.0%) from their portfolio in Q4 2025, for an estimated $122,539,733
- VIKING GLOBAL INVESTORS LP removed 1,583,915 shares (-9.9%) from their portfolio in Q4 2025, for an estimated $121,153,658
- WELLINGTON MANAGEMENT GROUP LLP added 1,329,537 shares (+130.4%) to their portfolio in Q4 2025, for an estimated $101,696,285
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,051,679 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $80,442,926
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BBIO Congressional Stock Trading
Members of Congress have traded $BBIO stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BBIO stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 3 purchases worth up to $45,000 on 03/19, 03/18, 03/03 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BBIO Analyst Ratings
Wall Street analysts have issued reports on $BBIO in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 03/10/2026
- Barclays issued a "Overweight" rating on 01/28/2026
- Truist Securities issued a "Buy" rating on 01/08/2026
- Morgan Stanley issued a "Overweight" rating on 01/06/2026
- JP Morgan issued a "Overweight" rating on 11/07/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/03/2025
- Goldman Sachs issued a "Buy" rating on 10/31/2025
To track analyst ratings and price targets for $BBIO, check out Quiver Quantitative's $BBIO forecast page.
$BBIO Price Targets
Multiple analysts have issued price targets for $BBIO recently. We have seen 17 analysts offer price targets for $BBIO in the last 6 months, with a median target of $98.0.
Here are some recent targets:
- Luca Issi from RBC Capital set a target price of $100.0 on 04/09/2026
- Salim Syed from Mizuho set a target price of $106.0 on 03/18/2026
- Anupam Rama from JP Morgan set a target price of $94.0 on 03/10/2026
- Cory Kasimov from Evercore ISI Group set a target price of $125.0 on 02/25/2026
- Sean Laaman from Morgan Stanley set a target price of $98.0 on 02/25/2026
- Danielle Brill from Truist Securities set a target price of $95.0 on 02/25/2026
- Trevor Allred from Oppenheimer set a target price of $81.0 on 02/25/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
